The BMO measured 1355 m in OD and 1445 m in OS
Acting fast helps stop bigger problems
One-Year Results Longer-term studies assess how much progress was maintained, whether weight reduction continued, how metabolic markers changed, and how well participants tolerated treatment over time
(D) Venn diagram showing genes whose RNA expression is dependent on LAG-1 at the various time points through transcriptomic analysis
Tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan and activate both GLP-1 and GIP receptors, offering an alternative for patients whose genetic profile suggests stronger response to dual-pathway activation
The team then administered orforglipron or another small-molecule drug, danuglipron, and identified brain regions where they induced activity